应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
JNJ 强生
交易中 03-10 13:00:09 EDT
243.85
+1.26
+0.52%
最高
244.63
最低
240.84
成交量
218.73万
今开
241.69
昨收
242.59
日振幅
1.56%
总市值
5,875亿
流通市值
5,863亿
总股本
24.09亿
成交额
5.31亿
换手率
0.09%
流通股本
24.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Tecvayli®▼ (Teclistamab)单药疗法申请提交至欧洲药品管理局，用于治疗至少接受过一种前期疗法的复发/难治性多发性骨髓瘤
美股速递 · 03-10 19:57
Tecvayli®▼ (Teclistamab)单药疗法申请提交至欧洲药品管理局，用于治疗至少接受过一种前期疗法的复发/难治性多发性骨髓瘤
强生多发性骨髓瘤组合疗法获FDA批准
环球市场播报 · 03-06
强生多发性骨髓瘤组合疗法获FDA批准
小摩上调强生目标价至250美元
格隆汇 · 03-06
小摩上调强生目标价至250美元
强生宣布Tecvayli®联合Darzalex Faspro®获美国FDA批准，用于复发/难治性多发性骨髓瘤，有望在二线治疗中树立新标准
美股速递 · 03-06
强生宣布Tecvayli®联合Darzalex Faspro®获美国FDA批准，用于复发/难治性多发性骨髓瘤，有望在二线治疗中树立新标准
强生猛将，空降默沙东！
张通社 · 03-04
强生猛将，空降默沙东！
1450亿元“砍骨”自救，强生果断断臂“整容”
华夏时报网 · 02-28
1450亿元“砍骨”自救，强生果断断臂“整容”
诺和诺德、诺华、强生、默沙东等“集体豪赌”，口服生物药这么难还要砸？
MedTrend医趋势 · 02-27
诺和诺德、诺华、强生、默沙东等“集体豪赌”，口服生物药这么难还要砸？
强生早期研究显示：帕西他米联合多西他赛在晚期前列腺癌中展现显著抗肿瘤活性
美股速递 · 02-27
强生早期研究显示：帕西他米联合多西他赛在晚期前列腺癌中展现显著抗肿瘤活性
强生联合疗法展现深度PSA缓解与良好安全性，计划推进至三期临床试验
美股速递 · 02-27
强生联合疗法展现深度PSA缓解与良好安全性，计划推进至三期临床试验
强生：联合疗法安全性与多西他赛单药相当，未现新发或意外不良信号
美股速递 · 02-27
强生：联合疗法安全性与多西他赛单药相当，未现新发或意外不良信号
法官驳回Kenvue撤销德州总检察长泰诺营销诉讼的请求
美股速递 · 02-27
法官驳回Kenvue撤销德州总检察长泰诺营销诉讼的请求
拜耳就前列腺癌药物营销问题起诉强生
格隆汇 · 02-24
拜耳就前列腺癌药物营销问题起诉强生
拜耳起诉强生，指控其前列腺癌药物虚假宣传
环球市场播报 · 02-24
拜耳起诉强生，指控其前列腺癌药物虚假宣传
欧盟批准皮下注射版Rybrevant®▼（Amivantamab）用于晚期EGFR突变非小细胞肺癌患者的每三周及每四周给药方案
美股速递 · 02-24
欧盟批准皮下注射版Rybrevant®▼（Amivantamab）用于晚期EGFR突变非小细胞肺癌患者的每三周及每四周给药方案
强生皮下注射版Amivantamab获准用于所有先前获批的静脉注射适应症
美股速递 · 02-24
强生皮下注射版Amivantamab获准用于所有先前获批的静脉注射适应症
黑石生命科学部门与强生将共同资助Bleximenib部分临床试验
美股速递 · 02-23
黑石生命科学部门与强生将共同资助Bleximenib部分临床试验
强生Tremfya（古塞奇尤单抗）三年长期数据证实对溃疡性结肠炎患者临床及内镜缓解效果持久
美股速递 · 02-21
强生Tremfya（古塞奇尤单抗）三年长期数据证实对溃疡性结肠炎患者临床及内镜缓解效果持久
Rybrevant Faspro™联合免疫疗法一线治疗复发或转移性头颈癌展现强劲临床获益，总缓解率达56%
美股速递 · 02-20
Rybrevant Faspro™联合免疫疗法一线治疗复发或转移性头颈癌展现强劲临床获益，总缓解率达56%
强生探索出售骨科业务 估值或超200亿美元
环球市场播报 · 02-20
强生探索出售骨科业务 估值或超200亿美元
强生股价短暂冲高 消息称公司正评估骨科业务部门
美股速递 · 02-20
强生股价短暂冲高 消息称公司正评估骨科业务部门
加载更多
公司概况
公司名称：
强生
所属市场：
NYSE
上市日期：
--
主营业务：
强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。
发行价格：
--
{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":243.845,"timestamp":1773162008836,"preClose":242.59,"halted":0,"volume":2187265,"delay":0,"changeRate":0.00517333773032687,"floatShares":2404573193,"shares":2409295102,"eps":11.03,"marketStatus":"交易中","change":1.255,"latestTime":"03-10 13:00:09 EDT","open":241.69,"high":244.63,"low":240.84,"amount":531459593.6709,"amplitude":0.015623,"askPrice":243.91,"askSize":401,"bidPrice":243.83,"bidSize":21,"shortable":3,"etf":0,"ttmEps":11.03,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":242.59,"dividendRate":0.021079,"preHourTrading":{"tag":"盘前","latestPrice":242.92,"preClose":242.59,"latestTime":"09:28 EDT","volume":4018,"amount":975986.90588,"timestamp":1773149334508,"change":0.33,"changeRate":0.00136,"amplitude":0.007791},"postHourTrading":{"tag":"盘后","latestPrice":242.065,"preClose":242.59,"latestTime":"19:59 EDT","volume":486318,"amount":117972182.1508,"timestamp":1773100741071,"change":-0.525,"changeRate":-0.002164,"amplitude":0.002844},"volumeRatio":0.556157,"impliedVol":0.2846,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"1126952419","title":"Tecvayli®▼ (Teclistamab)单药疗法申请提交至欧洲药品管理局，用于治疗至少接受过一种前期疗法的复发/难治性多发性骨髓瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1126952419","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126952419?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:57","pubTimestamp":1773143831,"startTime":"0","endTime":"0","summary":"强生公司已向欧洲药品管理局（EMA）提交了Tecvayli®▼ (Teclistamab)作为单药疗法的上市许可申请。该申请旨在寻求批准该药物用于治疗那些至少接受过一种前期疗法后仍出现复发或难治性的多发性骨髓瘤患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","JNJ","IE0002270589.USD","LU0203347892.USD","LU2129689514.USD","IE00BFTCPJ56.SGD","LU0124676726.USD","IE0034235303.USD","LU2129689605.HKD","BK4532","IE00BVYPNV92.GBP","LU0320765646.SGD","LU0432979614.USD","LU2471134879.HKD","BK4559","IE00B42XCP33.USD","LU1032955483.USD","SG9999001440.SGD","LU1162221912.USD","LU2089984988.USD","LU0640476718.USD","LU0787776722.HKD","LU2602419157.SGD","LU1221951046.USD","LU0795875086.SGD","LU1674673428.USD","IE0002141913.USD","LU0985320562.USD","SG9999002232.USD","LU0345770308.USD","BK4533","LU1221951129.SGD","LU0289739699.SGD","LU1983299246.USD","LU1585245621.USD","LU1074936037.SGD","LU0795875169.SGD","IE00B19Z3B42.SGD","LU2471134796.USD","LU0345770993.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU0683600562.USD","LU0792757196.USD","LU0114720955.EUR","LU0912757837.SGD","LU1778281490.HKD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU1066051811.HKD","IE00BVYPNW00.USD","LU2505996509.AUD","LU2592432038.USD","BK4588","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1732800096.USD","IE00BGHQF631.EUR","LU1732799900.SGD","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU1267930813.SGD","LU2129689431.USD","LU0345769128.USD","BK4504","LU2347655156.SGD","LU0889566641.SGD","LU1929549753.HKD","LU0058720904.USD","IE00B3T34201.USD","LU1032466523.USD","BK4550","LU1718418525.SGD","IE00BFXG1179.USD","LU1066053197.SGD","LU1059921491.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1894683348.USD","IE00B19Z3581.USD","IE00B3PB1722.GBP","LU0070217475.USD","LU1244550221.USD","LU1280957306.USD","IE00BBT3K403.USD","LU0234570918.USD","LU1066051225.USD","LU1261432733.SGD","LU2471134523.USD","LU0122379950.USD","LU2133065610.SGD","BK4581","BK4568","IE00BKVL7J92.USD","BK4585","LU2430703251.USD","LU2430703178.SGD","LU0098860793.USD","LU1244550577.SGD","LU1244550494.USD","BK4007","LU2430703095.HKD","IE00BZ1G4Q59.USD","LU2750360641.GBP","LU1196500208.SGD","BK4592","IE00BN8TJ469.HKD","LU0466842654.USD","LU1935042991.SGD","LU0345769631.USD","LU0882574055.USD","SG9999002224.SGD","LU0203345920.USD","IE0001KFT4U8.USD","LU0234572021.USD","LU1894683264.USD","LU2505996681.GBP","LU2471134952.CNY","LU2750360997.AUD","LU1430594728.SGD","IE00B2B36J28.USD","LU1506573853.SGD","LU1914381329.SGD","LU1057294990.SGD","IE00BDGV0183.EUR","LU1023059063.AUD","LU1674673691.USD","LU1496350502.SGD","LU2112291526.USD","IE00BLSP4239.USD","BK4534","LU0689626769.HKD"],"gpt_icon":0},{"id":"2617631379","title":"强生多发性骨髓瘤组合疗法获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631379","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617631379?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:08","pubTimestamp":1772806080,"startTime":"0","endTime":"0","summary":"美国食品与药品管理局（FDA）周五表示，在III期数据显示出显著的无进展生存期和总生存期获益后，强生的TECVAYLI联合DARZALEX FASPRO方案获得批准，用于治疗复发/难治性多发性骨髓瘤。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-06/doc-inhqahae2470435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1674673428.USD","BK4581","BK4504","IE00B19Z3581.USD","LU0792757196.USD","LU2430703178.SGD","LU2750360997.AUD","LU0289739699.SGD","LU1032466523.USD","LU1280957306.USD","LU1430594728.SGD","LU0466842654.USD","LU2129689514.USD","BK4568","LU1061106388.HKD","LU1221951129.SGD","LU1221951046.USD","LU1032955483.USD","IE0002141913.USD","LU2505996681.GBP","LU1066051225.USD","LU1718418525.SGD","BK4550","LU1929549753.HKD","IE00B1BXHZ80.USD","LU2089984988.USD","LU1732799900.SGD","LU2112291526.USD","LU1244550494.USD","LU0345769128.USD","IE00BN8TJ469.HKD","LU1066051811.HKD","JNJ","IE00BBT3K403.USD","LU0787776722.HKD","LU0889566641.SGD","BK4532","LU1894683348.USD","LU2129689431.USD","LU1023059063.AUD","SG9999001440.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU1244550221.USD","BK4533","BK4585","IE00B42XCP33.USD","LU0683600562.USD","LU1267930813.SGD","BK4588"],"gpt_icon":0},{"id":"2617881646","title":"小摩上调强生目标价至250美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617881646","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617881646?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:06","pubTimestamp":1772784402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BJJMRZ35.SGD","LU2430703251.USD","LU1057294990.SGD","LU0345769631.USD","IE00B7SZLL34.SGD","LU1162221912.USD","IE00BJT1NW94.SGD","LU1066051811.HKD","LU1066053197.SGD","BK4533","BK4588","LU1196500208.SGD","IE00BLSP4452.SGD","LU1059921491.USD","LU1066051225.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU2347655156.SGD","LU0345770308.USD","BK4592","BK4534","LU1023059063.AUD","LU1732800096.USD","LU1929549753.HKD","LU2129689605.HKD","LU2129689514.USD","LU2471134952.CNY","LU0122379950.USD","IE0034235303.USD","IE00BVYPNV92.GBP","LU0689626769.HKD","LU0234570918.USD","IE00B3T34201.USD","LU2471134523.USD","LU2112291526.USD","LU1032466523.USD","LU2592432038.USD","JNJ","LU1914381329.SGD","LU0203345920.USD","LU0234572021.USD","LU2750360997.AUD","LU2089984988.USD","LU1267930813.SGD","LU1244550577.SGD","LU1674673691.USD","LU0058720904.USD","LU1280957306.USD","LU1894683348.USD","LU1506573853.SGD"],"gpt_icon":0},{"id":"1189059267","title":"强生宣布Tecvayli®联合Darzalex Faspro®获美国FDA批准，用于复发/难治性多发性骨髓瘤，有望在二线治疗中树立新标准","url":"https://stock-news.laohu8.com/highlight/detail?id=1189059267","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189059267?lang=zh_cn&edition=full","pubTime":"2026-03-06 04:56","pubTimestamp":1772744173,"startTime":"0","endTime":"0","summary":"强生公司宣布，其Tecvayli®联合Darzalex Faspro®的治疗方案已获得美国食品药品监督管理局（FDA）的批准，用于治疗复发或难治性多发性骨髓瘤患者。\n这一批准意义重大，因为它为患者提供了一种潜在的全新护理标准，该方案甚至可在疾病的第二线治疗阶段就尽早使用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU0889566641.SGD","LU2750360997.AUD","LU0114720955.EUR","SG9999001440.SGD","LU2112291526.USD","LU1074936037.SGD","LU1066051498.USD","LU1280957306.USD","IE00BFTCPJ56.SGD","LU1059921491.USD","BK4550","LU1585245621.USD","LU1914381329.SGD","IE00B42XCP33.USD","LU0234570918.USD","LU2602419157.SGD","IE00BVYPNW00.USD","LU1674673691.USD","LU0122379950.USD","LU1066051225.USD","LU0058720904.USD","BK4568","BK4007","BK4585","LU1261432733.SGD","LU2430703178.SGD","BK4559","LU1267930813.SGD","IE00BGHQF631.EUR","LU2471134879.HKD","IE0002270589.USD","LU1496350502.SGD","IE00B2B36J28.USD","LU0345769128.USD","LU0345769631.USD","LU0345770993.USD","IE00BBT3K403.USD","LU1221951046.USD","LU0203347892.USD","IE0002141913.USD","LU2089984988.USD","LU0985320562.USD","IE000M9KFDE8.USD","LU0787776722.HKD","IE0001KFT4U8.USD","LU1023059063.AUD","LU0466842654.USD","LU0792757196.USD","IE00B19Z3B42.SGD","LU1196500208.SGD","IE00BZ1G4Q59.USD","LU1506573853.SGD","LU2430703095.HKD","LU0070217475.USD","IE00BDGV0183.EUR","IE0009355771.USD","LU0795875086.SGD","BK4534","LU1935042991.SGD","IE00B3T34201.USD","LU0320765646.SGD","IE00BVYPNV92.GBP","LU1244550221.USD","LU0882574055.USD","LU2129689514.USD","IE00BLSP4452.SGD","LU0345770308.USD","SG9999002224.SGD","BK4504","IE00BKVL7J92.USD","IE0034235303.USD","LU1674673428.USD","LU0289739699.SGD","LU0640476718.USD","LU1244550494.USD","IE00B4R5TH58.HKD","IE00B7SZLL34.SGD","LU2468319806.SGD","LU0124676726.USD","LU1244550577.SGD","IE00B3PB1722.GBP","LU0432979614.USD","LU0683600562.USD","LU0098860793.USD","LU2471134523.USD","LU2592432038.USD","LU1894683264.USD","LU1732799900.SGD","LU1732800096.USD","LU1221951129.SGD","LU1983299246.USD","LU0912757837.SGD","IE00BFXG1179.USD","LU1778281490.HKD","BK4592","IE00B1BXHZ80.USD","LU1066051811.HKD","SG9999002232.USD","LU0689626769.HKD","LU2430703251.USD","LU0234572021.USD","LU2133065610.SGD","BK4533","LU1032955483.USD","LU2471134952.CNY","LU1718418525.SGD","LU0203345920.USD","LU0795875169.SGD","LU1032466523.USD","IE00BLSP4239.USD","LU1162221912.USD","LU2750360641.GBP","LU1929549753.HKD","LU1066053197.SGD","IE00B19Z3581.USD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2129689431.USD","LU2471134796.USD","LU1894683348.USD","BK4581","LU2505996509.AUD","BK4588","LU1430594728.SGD","BK4532","IE00BN8TJ469.HKD","LU1061106388.HKD","LU2347655156.SGD","LU2129689605.HKD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2617687025","title":"强生猛将，空降默沙东！","url":"https://stock-news.laohu8.com/highlight/detail?id=2617687025","media":"张通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617687025?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:43","pubTimestamp":1772621012,"startTime":"0","endTime":"0","summary":"张通社 zhangtongshe.com｜源于张江、立足上海、服务科创｜近日，据业内消息，默沙东中国正式官宣重磅人事变动：任命强生创新制药前免疫治疗事业部负责人潘昉玥出任新设立的肿瘤事业部负责人。根据默沙东2月26日官宣，范柏睿将出任印度总经理，3月1日正式履职，新岗位直接向亚太区总裁汇报并进入亚太领导团队。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304185332a6a1dd43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304185332a6a1dd43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965509283.SGD","LU0985320562.USD","IE0009355771.USD","LU0234572021.USD","LU2461242641.AUD","LU2089984988.USD","IE00B3T34201.USD","LU0345770993.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1934455277.USD","IE00B2B36J28.USD","IE00BGHQF631.EUR","LU0106261372.USD","IE0002270589.USD","LU0070302665.USD","SG9999014542.SGD","LU0942090050.USD","LU1430594728.SGD","LU2471134952.CNY","SG9999013999.USD","IE0002141913.USD","IE0001KFT4U8.USD","LU0203345920.USD","LU0320765646.SGD","LU2750360997.AUD","JNJ","BK4504","SG9999015358.SGD","BK4533","LU0795875169.SGD","LU2592432038.USD","LU1718418525.SGD","LU0868494708.USD","IE00BVYPNW00.USD","BK4532","LU0265550946.USD","LU2468319806.SGD","LU2133065610.SGD","LU1941712264.USD","LU1291159041.SGD","LU0965509010.AUD","LU0058720904.USD","LU1196500208.SGD","LU1244550577.SGD","BK4534","SG9999001176.USD","LU0130517989.USD","IE00B19Z3581.USD","IE00BVYPNV92.GBP","LU0130102774.USD","IE00BSNM7G36.USD","LU1732799900.SGD","IE00BFXG1179.USD","LU2361044949.HKD","IE00BZ1G4Q59.USD","LU0795875086.SGD","LU2505996681.GBP","LU0320765489.SGD","LU0889566641.SGD","LU1066051811.HKD","BK4007","LU0266013472.USD","LU0787776722.HKD","LU0912757837.SGD","LU0345770308.USD","LU1674673691.USD","LU0345769631.USD","LU1585245621.USD","LU1059921491.USD","LU1914381329.SGD","LU2430703178.SGD","LU2360032135.SGD","BK4581","LU2750360641.GBP","LU0238689110.USD","LU1699723380.USD","LU1989771016.USD","LU1035773651.USD","LU1571399168.USD","LU1496350502.SGD","LU1929549753.HKD","LU2129689605.HKD","IE00B42XCP33.USD","LU1066051225.USD","LU1934455863.HKD","LU1221951129.SGD","LU0265550359.USD","LU2430703095.HKD","LU2471134523.USD","LU1116320901.HKD","LU1974910355.USD","LU0689626769.HKD","LU1221951046.USD","IE00BDGV0183.EUR","LU0466842654.USD","LU2471134879.HKD","LU2129689514.USD","LU1732800096.USD","IE0034235303.USD","IE00B3PB1722.GBP","IE00BBT3K403.USD","IE00B19Z3B42.SGD","MRK","LU0211331839.USD","LU0345769128.USD","LU1032466523.USD","IE00BKVL7J92.USD","SGXZ57979304.SGD","SG9999002224.SGD","BK4592","LU1674673428.USD","IE00BFTCPJ56.SGD","LU2361044865.SGD","SG9999001176.SGD","SG9999015341.SGD","BK4588","LU1506573853.SGD","LU0683600562.USD","LU1894683264.USD","LU1032955483.USD","LU1244550494.USD","LU2602419157.SGD","BK4568","LU2112291526.USD","SG9999014559.SGD","LU1244550221.USD","LU0882574055.USD","LU0006306889.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU0980610538.SGD","IE00BLSP4239.USD","LU2125154778.USD","LU1941712348.USD","LU0122379950.USD","LU2023250843.SGD","LU2125154935.USD","IE00BJJMRZ35.SGD","LU0477156953.USD","LU2361045086.USD","SG9999014567.USD","LU1989772923.USD","LU0289739699.SGD","BK4559","IE00B7SZLL34.SGD","LU1894683348.USD","LU1267930813.SGD","LU2430703251.USD","LU2505996509.AUD","LU0792757196.USD","IE00BLSP4452.SGD","LU0203347892.USD","LU1116320737.USD","LU0124676726.USD","LU1057294990.SGD","LU2471134796.USD","LU0234570918.USD","LU1935042991.SGD","LU2347655156.SGD","LU2023250504.SGD","LU0114720955.EUR","LU1093756325.SGD","LU1778281490.HKD","SG9999002232.USD","LU0965509101.SGD","LU1983299246.USD","SG9999001440.SGD","LU1061106388.HKD","LU0965508806.USD","LU0098860793.USD","LU1074936037.SGD","IE00B4R5TH58.HKD","LU1201861249.SGD","LU0070217475.USD","BK4516","LU1917777945.USD","LU1934455194.USD","LU2106854487.HKD","LU1023059063.AUD","LU1162221912.USD","LU1037948897.HKD","LU0208291251.USD","LU1280957306.USD","BK4585","LU0432979614.USD","LU1066053197.SGD","LU1066051498.USD","IE00BN8TJ469.HKD","LU0640476718.USD","LU1069347547.HKD","LU1261432733.SGD","LU1037948541.HKD","LU0861579265.USD","LU2324357040.USD","LU1989772840.SGD","SG9999014575.USD","LU0648001328.SGD","LU2129689431.USD","LU1093756168.USD","BK4550"],"gpt_icon":0},{"id":"2614313812","title":"1450亿元“砍骨”自救，强生果断断臂“整容”","url":"https://stock-news.laohu8.com/highlight/detail?id=2614313812","media":"华夏时报网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614313812?lang=zh_cn&edition=full","pubTime":"2026-02-28 21:04","pubTimestamp":1772283898,"startTime":"0","endTime":"0","summary":"强生曾经凭借“买买买”登上全球骨科之巅，如今却急于将曾经的基石业务“卖卖卖”。近日，据知情人士透露，医疗健康巨头强生公司（Johnson&Johnson,JNJ.N）正在重新评估其骨科业务DePuySynthes的剥离方案，考虑以超过200亿美元（折合人民币约1450亿元）的价格直接出售该部门，而非此前计划的分拆上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602283657564073.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602283657564073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0345770308.USD","LU0792757196.USD","LU1929549753.HKD","LU2471134796.USD","LU1162221912.USD","LU2089984988.USD","LU1061106388.HKD","LU0795875086.SGD","LU0114720955.EUR","LU0689626769.HKD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU2430703251.USD","IE0009355771.USD","LU1430594728.SGD","BK4532","LU2750360997.AUD","BK4533","BK4534","IE00BBT3K403.USD","LU0432979614.USD","LU2430703095.HKD","LU2471134523.USD","LU0234570918.USD","LU0882574055.USD","LU2129689431.USD","LU1496350502.SGD","LU1244550577.SGD","LU1032466523.USD","LU0345769631.USD","JNJ","LU2112291526.USD","LU2471134952.CNY","IE00BFXG1179.USD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU0124676726.USD","IE00BVYPNV92.GBP","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4568","IE00B42XCP33.USD","IE00BLSP4452.SGD","LU1718418525.SGD","LU2602419157.SGD","LU1032955483.USD","LU0795875169.SGD","IE0034235303.USD","LU0985320562.USD","LU0320765646.SGD"],"gpt_icon":0},{"id":"2614856698","title":"诺和诺德、诺华、强生、默沙东等“集体豪赌”，口服生物药这么难还要砸？","url":"https://stock-news.laohu8.com/highlight/detail?id=2614856698","media":"MedTrend医趋势","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614856698?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:44","pubTimestamp":1772189087,"startTime":"0","endTime":"0","summary":"2月25日，诺和诺德宣布与麻省理工学院传奇科学家Robert Langer实验室分拆公司Vivtex达成深度合作，交易总额最高达21亿美元，共同开发下一代代谢类药物的口服递送技术。2019年，诺和诺德Rybelsus在美获批上市，成为全球首个口服GLP-1受体激动剂。截至2025年底，其累计销售额已突破百亿美元量级，足以证明口服生物药的巨大潜力。人体本能地阻止大分子进入体内，这是生理保护机制。高盛预测，到2030年口服减重药将占据接近四分之一的市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227185632a4370c43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227185632a4370c43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0034235303.USD","LU2023250504.SGD","LU1196500208.SGD","LU1244550577.SGD","LU0154236417.USD","LU0912757837.SGD","LU1093756168.USD","IE00BVYPNV92.GBP","LU0234572021.USD","LU0466842654.USD","LU0792757196.USD","LU1929549753.HKD","SG9999014575.USD","LU1506573853.SGD","NVOX","01276","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","BK4578","LU0985320562.USD","LU0432979614.USD","IE00B3T34201.USD","LU0889566641.SGD","IE00BVYPNW00.USD","LU2471134523.USD","LU1917777945.USD","LU0345769631.USD","LU0795875086.SGD","LU1035773651.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","LU1935042991.SGD","LU2430703251.USD","IE00BLSP4452.SGD","MRK","IE000M9KFDE8.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU1934455277.USD","LU0980610538.SGD","LU0211331839.USD","LU0266013472.USD","LU0965509283.SGD","LU0106261372.USD","LU1032466523.USD","LU1496350502.SGD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","LU2129689605.HKD","LU1718418525.SGD","LU0683600562.USD","LU1244550494.USD","LU1732800096.USD","LU0648001328.SGD","LU2471134952.CNY","LU1778281490.HKD","LU1066053197.SGD","JNJ","LU2461242641.AUD","SG9999002232.USD","LU1674673428.USD","BK4533","IE00B2B36J28.USD","LU0006306889.USD","LU1066051225.USD","BK4516","IE00B19Z3581.USD","LU0234570918.USD","LU2602419157.SGD","BK4534","BK4532","LU2125154778.USD","LU1934455194.USD","LU2133065610.SGD","LU0787776722.HKD","BK4599","IE00B42XCP33.USD","IE0009355771.USD","LU0795875169.SGD","LU0203345920.USD","LU1074936037.SGD","LU2471134796.USD","LU2471134879.HKD","SG9999014559.SGD","BK4007","LU2361044865.SGD","LU1934455863.HKD","LU0689626769.HKD","LU0640476718.USD","LU1571399168.USD","LU1989771016.USD","LU0320765489.SGD","LU2089984988.USD","LU0965509101.SGD","LU1894683264.USD","BK4568","LU1983299246.USD","IE00BGHQF631.EUR","IE00BLSP4239.USD","LU0882574055.USD","IE0002141913.USD","LU2129689514.USD","LU1066051498.USD","LU2361045086.USD","LU0238689110.USD","LU1032955483.USD","LU1116320737.USD","LU2361044949.HKD","NVO","LU0070302665.USD","LU1585245621.USD","LU1057294990.SGD","LU0070217475.USD","LU0122379950.USD","LU1732799900.SGD","LU0345770308.USD","LU1941712264.USD","SG9999015341.SGD","LU0124676726.USD","LU2347655156.SGD","LU0130517989.USD","BK4550","SG9999015358.SGD","LU1914381329.SGD","IE00BKVL7J92.USD","LU0208291251.USD","LU0345770993.USD","BK4581","IE00BFTCPJ56.SGD","NVS","BK4504","LU2360032135.SGD","LU2750360641.GBP","LU1093756325.SGD","LU0345769128.USD","LU1699723380.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","LU0477156953.USD","IE0002270589.USD","LU2505996509.AUD","LU1261432733.SGD","LU2106854487.HKD","LU1941712348.USD","LU1221951046.USD","IE00BDGV0183.EUR","LU1974910355.USD","SG9999002224.SGD","IE00BSNM7G36.USD","BK4559","LU2023250843.SGD","LU0114720955.EUR","LU2430703095.HKD","LU2750360997.AUD","LU1674673691.USD","IE00BN8TJ469.HKD","NVOH","LU1059921491.USD","LU2125154935.USD","LU0058720904.USD","LU0320765646.SGD","LU1894683348.USD","SG9999001176.USD","LU1221951129.SGD","LU1116320901.HKD","LU1061106388.HKD","LU2129689431.USD","LU0289739699.SGD","SG9999014567.USD","LU0965509010.AUD","LU1267930813.SGD","BK4592","LU0130102774.USD","LU1037948541.HKD","LU1069347547.HKD","IE00B7SZLL34.SGD","IE00BBT3K403.USD","LU2430703178.SGD","SG9999014542.SGD","LU0098860793.USD","LU1162221912.USD","LU1430594728.SGD","LU0265550359.USD","LU2505996681.GBP","SG9999013999.USD","BK4588","IE00BFXG1179.USD","SG9999001176.SGD","LU1989772923.USD","LU2592432038.USD","SG9999001440.SGD","LU0265550946.USD","LU1023059063.AUD","LU0861579265.USD","LU1280957306.USD","LU2112291526.USD","LU1244550221.USD","LU2468319806.SGD","SGXZ57979304.SGD","LU0203347892.USD","LU0965508806.USD","BK4585","LU1291159041.SGD","IE00B3PB1722.GBP","LU1989772840.SGD","LU1037948897.HKD"],"gpt_icon":1},{"id":"1115702978","title":"强生早期研究显示：帕西他米联合多西他赛在晚期前列腺癌中展现显著抗肿瘤活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1115702978","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115702978?lang=zh_cn&edition=full","pubTime":"2026-02-27 03:31","pubTimestamp":1772134276,"startTime":"0","endTime":"0","summary":"强生公司最新公布的早期临床研究数据显示，其研发的帕西他米（Pasritamig）与标准化疗药物多西他赛联合治疗方案，在晚期前列腺癌患者群体中表现出令人鼓舞的抗肿瘤活性。\n该组合疗法在试验中展现出协同增效作用，不仅有效抑制了肿瘤生长，还显示出良好的安全性与耐受性特征。这一突破性进展为晚期前列腺癌患者提供了新的治疗希望，标志着靶向免疫疗法与化疗联合策略在该领域的重要突破。\n研究人员指出，后续将开展更大规模的临床试验，以进一步验证该联合疗法的长期疗效与临床应用潜力。此次研究成果有望为前列腺癌治疗指南的更新提供重要循证依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IE00BKVL7J92.USD","LU1674673691.USD","LU1261432733.SGD","LU1059921491.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00BLSP4239.USD","LU1267930813.SGD","LU1732800096.USD","LU2592432038.USD","IE00B42XCP33.USD","LU2471134879.HKD","IE00BBT3K403.USD","LU2347655156.SGD","LU0683600562.USD","BK4588","LU2430703095.HKD","LU2430703251.USD","LU0345770993.USD","IE00BFTCPJ56.SGD","IE00BVYPNW00.USD","LU1506573853.SGD","LU0889566641.SGD","IE00B2B36J28.USD","LU0203345920.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU0640476718.USD","LU1935042991.SGD","IE00BSNM7G36.USD","IE00B3PB1722.GBP","LU1244550494.USD","IE0002270589.USD","IE00BVYPNV92.GBP","LU2471134796.USD","IE00B19Z3B42.SGD","LU2505996681.GBP","LU1066051498.USD","LU0345769128.USD","IE0034235303.USD","BK4532","LU1032466523.USD","LU0432979614.USD","LU0070217475.USD","LU0345769631.USD","IE00B19Z3581.USD","LU2133065610.SGD","LU2471134952.CNY","BK4534","IE0001KFT4U8.USD","LU0912757837.SGD","LU1280957306.USD","BK4550","LU2602419157.SGD","SG9999002232.USD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU2750360641.GBP","BK4533","LU0234570918.USD","IE00BFXG1179.USD","IE00BLSP4452.SGD","LU1244550221.USD","LU1496350502.SGD","IE00B7SZLL34.SGD","LU1074936037.SGD","BK4581","LU2129689514.USD","IE00B3T34201.USD","IE00BN8TJ469.HKD","LU1778281490.HKD","LU1732799900.SGD","LU1023059063.AUD","IE0002141913.USD","BK4592","LU0882574055.USD","LU0122379950.USD","LU0234572021.USD","LU0795875169.SGD","LU1066053197.SGD","LU0320765646.SGD","LU0792757196.USD","LU0795875086.SGD","LU1221951046.USD","LU2750360997.AUD","LU2089984988.USD","LU1244550577.SGD","BK4504","LU1066051225.USD","LU1585245621.USD","LU1061106388.HKD","LU2471134523.USD","LU0345770308.USD","LU1162221912.USD","LU1894683348.USD","LU1983299246.USD","LU0466842654.USD","LU1057294990.SGD","BK4559","IE00BDGV0183.EUR","LU0689626769.HKD","LU0114720955.EUR","LU0098860793.USD","LU1914381329.SGD","LU1674673428.USD","LU2505996509.AUD","LU1032955483.USD","SG9999001440.SGD","LU2129689605.HKD","LU0985320562.USD","LU2112291526.USD","IE0009355771.USD","LU1196500208.SGD","LU2430703178.SGD","JNJ","LU1221951129.SGD","SG9999002224.SGD","BK4007","BK4585","LU0058720904.USD","LU1430594728.SGD","IE00B1BXHZ80.USD","LU0124676726.USD","IE000M9KFDE8.USD","LU2129689431.USD","LU1929549753.HKD","LU1894683264.USD","LU2468319806.SGD","LU0787776722.HKD","LU0203347892.USD","LU1718418525.SGD"],"gpt_icon":0},{"id":"1188195957","title":"强生联合疗法展现深度PSA缓解与良好安全性，计划推进至三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1188195957","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188195957?lang=zh_cn&edition=full","pubTime":"2026-02-27 03:31","pubTimestamp":1772134275,"startTime":"0","endTime":"0","summary":"强生公司最新公布的研究数据显示，其开发的联合治疗方案在临床试验中表现出显著的深度前列腺特异性抗原缓解效果，同时具备良好的安全性与耐受性特征。\n基于这些积极结果，该公司已制定明确计划，准备将该项疗法推进至三期临床研究阶段，以进一步验证其疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935042991.SGD","IE00BJT1NW94.SGD","LU1280957306.USD","LU2112291526.USD","LU0795875169.SGD","LU1066053197.SGD","LU0234570918.USD","IE00B1BXHZ80.USD","LU0792757196.USD","IE00BSNM7G36.USD","LU1162221912.USD","LU1221951129.SGD","LU1267930813.SGD","LU1506573853.SGD","LU1718418525.SGD","IE00BZ1G4Q59.USD","IE00BDGV0183.EUR","LU1585245621.USD","LU1929549753.HKD","JNJ","LU0320765646.SGD","LU0683600562.USD","LU1244550494.USD","BK4007","LU0795875086.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4534","LU1430594728.SGD","LU1496350502.SGD","LU1914381329.SGD","LU1983299246.USD","IE00BFXG1179.USD","IE00B19Z3B42.SGD","LU0345769631.USD","BK4504","IE0002141913.USD","LU0098860793.USD","IE00B2B36J28.USD","LU2750360997.AUD","LU0345770308.USD","SG9999001440.SGD","LU2430703251.USD","LU0114720955.EUR","LU1674673428.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4588","LU2602419157.SGD","LU2129689514.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU1732799900.SGD","LU0289739699.SGD","IE00B19Z3581.USD","LU0689626769.HKD","BK4568","BK4559","IE00B42XCP33.USD","IE00BGHQF631.EUR","LU0466842654.USD","LU2471134952.CNY","LU1066051498.USD","BK4550","LU2592432038.USD","LU2471134796.USD","SG9999002232.USD","LU1674673691.USD","LU1074936037.SGD","LU2129689605.HKD","BK4592","IE00BVYPNW00.USD","IE00BLSP4452.SGD","SG9999002224.SGD","LU0345769128.USD","LU2750360641.GBP","LU1778281490.HKD","LU2430703095.HKD","LU2505996681.GBP","LU2129689431.USD","LU0432979614.USD","LU1221951046.USD","IE00B4R5TH58.HKD","IE00B3T34201.USD","LU1032466523.USD","LU1894683348.USD","LU1244550577.SGD","BK4533","LU1261432733.SGD","LU2505996509.AUD","IE0034235303.USD","LU0058720904.USD","LU0203345920.USD","IE0001KFT4U8.USD","LU0070217475.USD","LU0882574055.USD","BK4585","LU1059921491.USD","IE00BN8TJ469.HKD","IE00BKVL7J92.USD","LU0122379950.USD","LU2089984988.USD","LU0889566641.SGD","BK4532","LU0985320562.USD","IE0002270589.USD","LU0124676726.USD","LU0787776722.HKD","LU2471134879.HKD","LU2133065610.SGD","LU0640476718.USD","LU1057294990.SGD","LU1196500208.SGD","IE00B3PB1722.GBP","BK4581","LU0234572021.USD","LU0912757837.SGD","LU2430703178.SGD","IE0009355771.USD","IE00BBT3K403.USD","LU0203347892.USD","LU1894683264.USD","LU1066051225.USD","IE00BVYPNV92.GBP","LU1732800096.USD","LU1066051811.HKD","LU2468319806.SGD","LU0345770993.USD","LU1244550221.USD","IE00BFTCPJ56.SGD","LU2347655156.SGD","LU1032955483.USD","LU2471134523.USD"],"gpt_icon":0},{"id":"1199340427","title":"强生：联合疗法安全性与多西他赛单药相当，未现新发或意外不良信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1199340427","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199340427?lang=zh_cn&edition=full","pubTime":"2026-02-27 03:31","pubTimestamp":1772134272,"startTime":"0","endTime":"0","summary":"强生公司公布的数据显示，其联合治疗方案的安全特性与单独使用多西他赛时表现一致。在整个研究观察期间，未发现任何新的或超出预期的安全性警示信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1066053197.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0792757196.USD","IE0002270589.USD","LU2129689431.USD","LU0114720955.EUR","LU0689626769.HKD","IE00BLSP4239.USD","LU0203345920.USD","LU0912757837.SGD","IE00BVYPNW00.USD","BK4534","LU0432979614.USD","LU1023059063.AUD","BK4532","LU0795875169.SGD","LU1059921491.USD","LU1074936037.SGD","BK4568","LU0234572021.USD","LU0882574055.USD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","LU1066051225.USD","BK4504","IE00BLSP4452.SGD","LU0098860793.USD","LU0683600562.USD","LU1196500208.SGD","LU0466842654.USD","LU1032466523.USD","LU2430703178.SGD","IE00BJJMRZ35.SGD","LU1066051811.HKD","LU1221951129.SGD","IE00B42XCP33.USD","IE00BBT3K403.USD","BK4585","LU2592432038.USD","LU2750360997.AUD","IE00BSNM7G36.USD","LU1267930813.SGD","LU2471134879.HKD","LU2471134952.CNY","LU1585245621.USD","IE00BVYPNV92.GBP","LU2471134796.USD","LU0058720904.USD","LU1066051498.USD","LU0345769128.USD","LU0122379950.USD","LU1261432733.SGD","LU0070217475.USD","LU1032955483.USD","LU1244550494.USD","LU0795875086.SGD","LU1894683348.USD","IE00B4R5TH58.HKD","SG9999002224.SGD","BK4550","LU1778281490.HKD","LU0320765646.SGD","LU1061106388.HKD","LU0640476718.USD","LU2505996681.GBP","LU2347655156.SGD","SG9999002232.USD","LU1983299246.USD","LU2089984988.USD","LU1935042991.SGD","LU1506573853.SGD","LU0889566641.SGD","IE00BZ1G4Q59.USD","LU2129689514.USD","LU1674673691.USD","LU0345770308.USD","LU0985320562.USD","LU1162221912.USD","IE00BJT1NW94.SGD","LU0345769631.USD","LU2505996509.AUD","LU1244550577.SGD","LU1430594728.SGD","LU1732800096.USD","LU1674673428.USD","LU2468319806.SGD","BK4533","IE0034235303.USD","IE00B19Z3B42.SGD","BK4588","LU1929549753.HKD","IE00BKVL7J92.USD","IE000M9KFDE8.USD","IE00BFXG1179.USD","BK4581","LU0289739699.SGD","LU1718418525.SGD","BK4559","IE00BDGV0183.EUR","LU2133065610.SGD","BK4592","LU2430703095.HKD","LU0124676726.USD","LU1914381329.SGD","LU0787776722.HKD","LU2129689605.HKD","LU2750360641.GBP","IE00BFTCPJ56.SGD","LU1496350502.SGD","IE00BN8TJ469.HKD","IE00B3T34201.USD","LU1221951046.USD","LU0203347892.USD","LU1057294990.SGD","LU1280957306.USD","LU1894683264.USD","JNJ","LU1732799900.SGD","IE00B7SZLL34.SGD","LU2430703251.USD","IE00B3PB1722.GBP","LU2602419157.SGD","LU0234570918.USD","LU2112291526.USD","LU2471134523.USD","LU1244550221.USD","LU0345770993.USD","IE00BGHQF631.EUR","BK4007","SG9999001440.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1111664867","title":"法官驳回Kenvue撤销德州总检察长泰诺营销诉讼的请求","url":"https://stock-news.laohu8.com/highlight/detail?id=1111664867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111664867?lang=zh_cn&edition=full","pubTime":"2026-02-27 00:03","pubTimestamp":1772121838,"startTime":"0","endTime":"0","summary":"根据法庭命令显示，Kenvue公司提出的撤销德州总检察长就其泰诺产品营销行为提起诉讼的动议已被法官正式驳回。这标志着针对该制药企业营销实践的法律争议将继续进入实质性审理阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703095.HKD","BK4588","LU1196500208.SGD","LU1935042991.SGD","IE00B4R5TH58.HKD","BK4504","LU0683600562.USD","IE0002141913.USD","LU2129689514.USD","IE000M9KFDE8.USD","LU0098860793.USD","IE00BGHQF631.EUR","IE00BLSP4239.USD","LU1914381329.SGD","IE00B3PB1722.GBP","LU1267930813.SGD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","BK4559","IE00B42XCP33.USD","IE00BVYPNW00.USD","LU0122379950.USD","LU2471134523.USD","LU1066051498.USD","LU0320765646.SGD","LU2471134796.USD","LU1894683348.USD","LU2750360641.GBP","SG9999001440.SGD","LU0640476718.USD","BK4007","LU1732800096.USD","LU0234572021.USD","LU0128525929.USD","LU0234570918.USD","IE00BBT3K403.USD","IE0001KFT4U8.USD","BK4183","LU2468319806.SGD","LU0310800379.SGD","LU1718418525.SGD","LU1032955483.USD","LU1074936037.SGD","IE00B2B36J28.USD","LU1894683264.USD","LU0689626769.HKD","LU0795875169.SGD","IE00B1BXHZ80.USD","LU1430594728.SGD","IE00BDGV0183.EUR","BK4532","LU0114720955.EUR","LU1280957306.USD","LU1929549753.HKD","LU0889566641.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU2430703251.USD","LU0345769631.USD","BK4581","LU0345769128.USD","LU1032466523.USD","LU1585245621.USD","LU0466842654.USD","LU0289739699.SGD","BK4534","IE00BN8TJ469.HKD","LU0345770993.USD","LU0203347892.USD","LU0708994859.HKD","LU0345770308.USD","LU2750360997.AUD","LU1244550577.SGD","SG9999002232.USD","LU2089984988.USD","LU2602419157.SGD","LU0029864427.USD","BK4533","LU0203345920.USD","LU2129689431.USD","IE00B19Z3581.USD","LU2505996681.GBP","IE00BJT1NW94.SGD","LU1732799900.SGD","LU1244550221.USD","IE00BLSP4452.SGD","LU2471134952.CNY","LU1066051225.USD","LU1061106388.HKD","LU1162221912.USD","LU1244550494.USD","LU0432979614.USD","LU0985320562.USD","LU0795875086.SGD","LU1496350502.SGD","IE00B19Z3B42.SGD","LU2133065610.SGD","LU1221951129.SGD","SG9999002224.SGD","LU1506573853.SGD","LU1057294990.SGD","LU0124676726.USD","LU1066053197.SGD","LU2430703178.SGD","BK4592","LU0792757196.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BKVL7J92.USD","LU1023059063.AUD","LU1261432733.SGD","LU1674673428.USD","LU2471134879.HKD","JNJ","BK4585","LU1221951046.USD","LU0882574055.USD","IE0034235303.USD","LU1983299246.USD","LU2347655156.SGD","LU1778281490.HKD","LU2505996509.AUD","LU2112291526.USD","LU0912757837.SGD","IE00BVYPNV92.GBP","IE00B7SZLL34.SGD","LU1066051811.HKD","LU1674673691.USD","LU0787776722.HKD","LU2129689605.HKD","LU2592432038.USD","LU0070217475.USD","KVUE","BK4550","IE0002270589.USD","BK4568","LU0058720904.USD","LU1059921491.USD","IE00BZ1G4Q59.USD","LU1267930573.SGD"],"gpt_icon":0},{"id":"2613757536","title":"拜耳就前列腺癌药物营销问题起诉强生","url":"https://stock-news.laohu8.com/highlight/detail?id=2613757536","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613757536?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:03","pubTimestamp":1771898618,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0345770308.USD","BK4533","BK4585","IE00B42XCP33.USD","LU1914381329.SGD","BK4534","BK4007","IE00BJT1NW94.SGD","IE00BBT3K403.USD","BK4568","BK4550","IE00BFXG1179.USD","LU1894683264.USD","LU2468319806.SGD","SG9999002232.USD","LU0792757196.USD","LU1244550494.USD","LU1929549753.HKD","LU2133065610.SGD","LU0114720955.EUR","IE00B2B36J28.USD","LU1196500208.SGD","LU0122379950.USD","LU1674673691.USD","BK4504","LU2505996509.AUD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1059921491.USD","LU0234570918.USD","LU0985320562.USD","LU1506573853.SGD","LU1674673428.USD","IE00B3T34201.USD","LU0889566641.SGD","LU0320765646.SGD","LU1244550577.SGD","LU0345769128.USD","LU0466842654.USD","LU1280957306.USD","IE0001KFT4U8.USD","BK4588","IE0002270589.USD","LU0912757837.SGD","LU1732800096.USD","IE0002141913.USD","LU2129689514.USD","LU0882574055.USD","LU1074936037.SGD","JNJ"],"gpt_icon":0},{"id":"2613736364","title":"拜耳起诉强生，指控其前列腺癌药物虚假宣传","url":"https://stock-news.laohu8.com/highlight/detail?id=2613736364","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613736364?lang=zh_cn&edition=full","pubTime":"2026-02-24 01:03","pubTimestamp":1771866180,"startTime":"0","endTime":"0","summary":"拜耳周一起诉强生，指控这家竞争对手制药企业对一款用于治疗前列腺癌的药物进行虚假宣传。\n 根据向曼哈顿联邦法院提交的诉状，强生为推广并标榜自家药物厄利达（Erleada） 的所谓优势，针对拜耳的诺倍戈（Nubeqa） 药物发起了虚假宣传活动。\n 拜耳正在寻求三倍损害赔偿、追回强生通过不正当手段获得的利润，并申请禁令以阻止强生所谓的虚假宣传行为。\n 强生尚未立即回应置评请求。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-24/doc-inhnvuma9380249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0122379950.USD","LU0289739699.SGD","LU0345770308.USD","LU1261432733.SGD","SG9999002224.SGD","LU1066053197.SGD","LU2471134879.HKD","IE00BLSP4239.USD","LU1066051498.USD","LU2471134952.CNY","BK4581","LU0114720955.EUR","LU1023059063.AUD","LU0234572021.USD","LU1506573853.SGD","LU1732799900.SGD","IE00B3PB1722.GBP","LU0689626769.HKD","LU0640476718.USD","LU1032955483.USD","IE0002270589.USD","IE00BDGV0183.EUR","LU2133065610.SGD","IE00B2B36J28.USD","LU1674673428.USD","BK4588","BK4550","LU1059921491.USD","LU1061106388.HKD","BK4568","IE00BFTCPJ56.SGD","LU0203345920.USD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU0432979614.USD","LU0098860793.USD","BK4533","IE00BLSP4452.SGD","IE0001KFT4U8.USD","LU1267930813.SGD","LU1929549753.HKD","BK4007","LU2468319806.SGD","LU1221951046.USD","JNJ","LU1066051811.HKD","LU1914381329.SGD","LU0234570918.USD","LU0124676726.USD","LU1280957306.USD"],"gpt_icon":0},{"id":"1128631880","title":"欧盟批准皮下注射版Rybrevant®▼（Amivantamab）用于晚期EGFR突变非小细胞肺癌患者的每三周及每四周给药方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1128631880","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128631880?lang=zh_cn&edition=full","pubTime":"2026-02-24 00:21","pubTimestamp":1771863672,"startTime":"0","endTime":"0","summary":"欧盟委员会已正式批准强生公司旗下皮下注射制剂Rybrevant®▼（Amivantamab）用于治疗晚期EGFR突变非小细胞肺癌患者，新增每三周一次和每四周一次的给药方案。这一决定为患者提供了更为灵活的治疗选择，有望改善治疗便利性与生活质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","SG9999002224.SGD","IE0002270589.USD","IE00B19Z3581.USD","BK4581","LU1430594728.SGD","LU1244550577.SGD","LU0466842654.USD","LU1506573853.SGD","LU0792757196.USD","IE00BDGV0183.EUR","IE00BKVL7J92.USD","LU2112291526.USD","LU1894683348.USD","LU1496350502.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4588","LU0070217475.USD","LU1074936037.SGD","LU0234572021.USD","IE00BN8TJ469.HKD","IE0001KFT4U8.USD","IE0034235303.USD","IE00B3PB1722.GBP","IE000M9KFDE8.USD","LU1280957306.USD","LU1196500208.SGD","BK4504","LU1244550494.USD","LU1929549753.HKD","LU1674673428.USD","LU1983299246.USD","LU1066051498.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU1032955483.USD","LU1066053197.SGD","IE0009355771.USD","LU0320765646.SGD","LU1244550221.USD","LU0912757837.SGD","SG9999002232.USD","LU2750360997.AUD","LU1261432733.SGD","LU1221951129.SGD","LU0203345920.USD","LU0689626769.HKD","LU2347655156.SGD","IE00B7SZLL34.SGD","SG9999001440.SGD","LU0345769128.USD","LU2505996509.AUD","IE00B3T34201.USD","LU0640476718.USD","LU1032466523.USD","LU1066051225.USD","LU2129689514.USD","LU1732799900.SGD","LU0058720904.USD","LU1914381329.SGD","LU0345769631.USD","BK4568","LU2750360641.GBP","LU0098860793.USD","LU0795875086.SGD","LU1059921491.USD","LU1718418525.SGD","LU2133065610.SGD","LU2471134796.USD","BK4007","LU0882574055.USD","LU1894683264.USD","BK4532","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU2471134523.USD","LU0345770308.USD","LU2468319806.SGD","LU1674673691.USD","LU1778281490.HKD","BK4559","LU1023059063.AUD","LU1585245621.USD","LU2129689605.HKD","LU1267930813.SGD","LU2471134879.HKD","IE00BSNM7G36.USD","IE00BFXG1179.USD","IE00BVYPNW00.USD","LU0122379950.USD","LU2430703251.USD","LU0345770993.USD","IE00BVYPNV92.GBP","LU0985320562.USD","LU1732800096.USD","LU1935042991.SGD","JNJ","BK4585","IE00BFTCPJ56.SGD","BK4533","LU2602419157.SGD","LU1221951046.USD","LU0889566641.SGD","IE0002141913.USD","LU2129689431.USD","LU2430703178.SGD","LU1162221912.USD","LU0432979614.USD","LU2505996681.GBP","BK4534","LU0683600562.USD","LU0234570918.USD","LU0795875169.SGD","LU0203347892.USD","IE00BBT3K403.USD","LU0787776722.HKD","LU0124676726.USD","IE00B1BXHZ80.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU1066051811.HKD","IE00BGHQF631.EUR","IE00B42XCP33.USD","LU1057294990.SGD","BK4592","LU2592432038.USD","LU2430703095.HKD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","BK4550","LU2471134952.CNY"],"gpt_icon":0},{"id":"1100354748","title":"强生皮下注射版Amivantamab获准用于所有先前获批的静脉注射适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1100354748","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100354748?lang=zh_cn&edition=full","pubTime":"2026-02-24 00:21","pubTimestamp":1771863672,"startTime":"0","endTime":"0","summary":"强生公司宣布，其皮下注射（SC）剂型的Amivantamab现已获得授权，可用于所有先前已获批的静脉注射（IV）Amivantamab的适应症。这一授权意味着该药物在更便捷的给药方式下，其应用范围得到了正式扩展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134796.USD","IE0002141913.USD","SG9999002224.SGD","IE00B7SZLL34.SGD","LU1244550577.SGD","IE00B2B36J28.USD","LU2505996509.AUD","LU0466842654.USD","LU2750360641.GBP","LU1061106388.HKD","LU1244550494.USD","IE00BVYPNV92.GBP","IE00BFTCPJ56.SGD","LU0124676726.USD","LU1221951129.SGD","LU1894683264.USD","LU0320765646.SGD","LU1196500208.SGD","IE00B1BXHZ80.USD","SG9999001440.SGD","LU0683600562.USD","BK4532","BK4007","LU1430594728.SGD","LU1585245621.USD","LU1244550221.USD","LU0795875169.SGD","BK4559","IE00BN8TJ469.HKD","LU1032466523.USD","LU2112291526.USD","LU1983299246.USD","BK4533","LU0792757196.USD","LU1057294990.SGD","LU2089984988.USD","LU1261432733.SGD","LU0889566641.SGD","LU1066051811.HKD","LU2133065610.SGD","LU1066051225.USD","BK4504","LU2471134879.HKD","IE00BGHQF631.EUR","LU1718418525.SGD","LU0882574055.USD","LU0345769128.USD","LU2468319806.SGD","LU1496350502.SGD","IE00BJJMRZ35.SGD","LU0098860793.USD","BK4581","JNJ","LU1894683348.USD","LU0640476718.USD","LU1778281490.HKD","LU0058720904.USD","IE0034235303.USD","LU0345769631.USD","LU0234570918.USD","IE00BVYPNW00.USD","LU0345770308.USD","LU1221951046.USD","LU1674673428.USD","LU0787776722.HKD","IE00BJT1NW94.SGD","LU2430703178.SGD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU1059921491.USD","IE00B3T34201.USD","IE00BLSP4452.SGD","LU0289739699.SGD","LU1162221912.USD","LU2592432038.USD","IE00BDGV0183.EUR","IE000M9KFDE8.USD","LU2347655156.SGD","SG9999002232.USD","LU0345770993.USD","IE0001KFT4U8.USD","IE00B19Z3581.USD","LU1066051498.USD","LU1506573853.SGD","LU0114720955.EUR","LU2430703095.HKD","BK4588","IE00BZ1G4Q59.USD","LU1280957306.USD","LU2129689431.USD","BK4585","LU2129689514.USD","LU1674673691.USD","LU0795875086.SGD","LU0912757837.SGD","LU2471134952.CNY","LU0203345920.USD","LU0203347892.USD","LU0070217475.USD","IE00BLSP4239.USD","IE00B3PB1722.GBP","LU1935042991.SGD","LU1074936037.SGD","IE00BFXG1179.USD","IE0002270589.USD","IE00B42XCP33.USD","LU2129689605.HKD","LU1732799900.SGD","IE0009355771.USD","LU0122379950.USD","LU1914381329.SGD","LU0985320562.USD","IE00B4R5TH58.HKD","BK4534","BK4592","BK4568","LU1929549753.HKD","IE00B19Z3B42.SGD","LU1732800096.USD","BK4550","LU1066053197.SGD","LU2430703251.USD","LU2750360997.AUD","LU1023059063.AUD","LU2505996681.GBP","LU2471134523.USD","LU1267930813.SGD","LU2602419157.SGD","LU0432979614.USD","LU1032955483.USD","LU0689626769.HKD","LU0234572021.USD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"1153526917","title":"黑石生命科学部门与强生将共同资助Bleximenib部分临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1153526917","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153526917?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:01","pubTimestamp":1771848078,"startTime":"0","endTime":"0","summary":"黑石集团旗下生命科学部门与强生公司宣布达成合作协议，双方将共同出资支持Bleximenib药物的部分临床试验项目。此次合作旨在加速该创新疗法的研发进程，为患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0320765646.SGD","IE00BLSP4452.SGD","LU0795875086.SGD","LU0203347892.USD","LU0787776722.HKD","LU2750360641.GBP","LU0070217475.USD","LU0098860793.USD","IE0002141913.USD","LU1221951046.USD","IE0009355771.USD","LU1066053197.SGD","IE0004445239.USD","LU2471134952.CNY","BK4588","IE0002270589.USD","LU1066051498.USD","LU2430703178.SGD","IE00BBT3K403.USD","IE00BFXG1179.USD","LU1778281490.HKD","LU2471134879.HKD","IE00BFTCPJ56.SGD","LU1732800096.USD","LU0912757837.SGD","LU0466842654.USD","BK4585","LU1221951129.SGD","LU0203345920.USD","BK4532","LU0345769128.USD","LU1718418525.SGD","LU1935042991.SGD","LU2592432038.USD","LU1057294990.SGD","LU1894683348.USD","BK4559","LU0889566641.SGD","IE00BGHQF631.EUR","LU0432979614.USD","LU0792757196.USD","IE00BGHQF748.EUR","BK4568","LU1162221912.USD","LU2750360997.AUD","IE00BKVL7J92.USD","BK4504","IE00B3T34201.USD","LU1267930813.SGD","LU2129689605.HKD","LU0058720904.USD","LU0795875169.SGD","LU2468319806.SGD","LU0683600562.USD","LU1983299246.USD","LU2347655156.SGD","LU0689626769.HKD","LU2505996509.AUD","LU1032466523.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","IE00BVYPNW00.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU1929549753.HKD","IE00B3PB1722.GBP","LU1506573853.SGD","LU2505996681.GBP","BK4581","LU1244550494.USD","LU0289739699.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU1023059063.AUD","BK4592","LU2133065610.SGD","LU2602419157.SGD","LU1066051225.USD","BK4534","BK4007","LU1674673691.USD","LU1430594728.SGD","JNJ","SG9999001440.SGD","IE00B7SZLL34.SGD","IE00B3QW5Z07.USD","BK4550","LU1496350502.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU0345770308.USD","LU1061106388.HKD","LU0345769631.USD","LU0122379950.USD","BX","IE00B64PRP62.GBP","LU2471134523.USD","IE00B19Z3B42.SGD","LU1914381329.SGD","LU0985320562.USD","LU1032955483.USD","IE00BDGV0183.EUR","LU2471134796.USD","IE0001KFT4U8.USD","LU2430703095.HKD","BK4533","IE00B42XCP33.USD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU1894683264.USD","LU0234570918.USD","LU0882574055.USD","LU0114720955.EUR","LU1674673428.USD","LU2112291526.USD","LU1059921491.USD","LU2129689431.USD","IE00BVYPNV92.GBP","LU1074936037.SGD","IE00BSNM7G36.USD","LU0640476718.USD","IE0034235303.USD","BK4135","SG9999002224.SGD","LU1196500208.SGD","LU2430703251.USD","LU1280957306.USD","LU1244550221.USD","LU0345770993.USD","LU2089984988.USD","IE00BLSP4239.USD","LU1585245621.USD","LU0234572021.USD","LU0124676726.USD","LU1732799900.SGD","LU2129689514.USD","LU1066051811.HKD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"1185015314","title":"强生Tremfya（古塞奇尤单抗）三年长期数据证实对溃疡性结肠炎患者临床及内镜缓解效果持久","url":"https://stock-news.laohu8.com/highlight/detail?id=1185015314","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185015314?lang=zh_cn&edition=full","pubTime":"2026-02-21 21:01","pubTimestamp":1771678877,"startTime":"0","endTime":"0","summary":"强生公司旗下药物Tremfya（古塞奇尤单抗）最新公布的长期研究数据显示，该药物在治疗溃疡性结肠炎方面展现出持久的疗效。经过长达三年的持续观察，研究证实患者能够维持临床及内镜下的症状缓解状态。\n这一结果凸显了Tremfya在长期疾病管理中的稳定性，为溃疡性结肠炎患者提供了可持续的治疗选择。数据进一步支持该药物在控制病情进展和促进黏膜愈合方面的持续益处。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","LU1057294990.SGD","LU1267930813.SGD","LU1718418525.SGD","BK4534","LU2133065610.SGD","LU2129689431.USD","LU1935042991.SGD","LU2089984988.USD","LU1244550577.SGD","LU2112291526.USD","IE00B1BXHZ80.USD","BK4533","BK4585","LU1506573853.SGD","BK4581","LU2505996509.AUD","LU2430703251.USD","LU2471134523.USD","LU1061106388.HKD","LU0345770308.USD","LU1430594728.SGD","LU1261432733.SGD","LU1023059063.AUD","IE0002141913.USD","LU2471134796.USD","LU0203345920.USD","LU2129689605.HKD","SG9999001440.SGD","LU2592432038.USD","LU0689626769.HKD","IE000M9KFDE8.USD","IE00BBT3K403.USD","BK4568","LU1732800096.USD","LU2430703095.HKD","IE0009355771.USD","LU1196500208.SGD","LU1221951046.USD","LU0795875169.SGD","IE00B3T34201.USD","IE00B2B36J28.USD","IE00B7SZLL34.SGD","LU0985320562.USD","LU1032466523.USD","LU1059921491.USD","LU1066051225.USD","LU1074936037.SGD","LU0058720904.USD","LU0882574055.USD","LU0466842654.USD","SG9999002224.SGD","LU1032955483.USD","LU0234570918.USD","LU1894683264.USD","BK4592","IE0001KFT4U8.USD","IE00BFXG1179.USD","IE00BKVL7J92.USD","IE00BVYPNV92.GBP","LU0345769631.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","LU2430703178.SGD","LU0070217475.USD","LU0432979614.USD","LU0792757196.USD","IE00BFTCPJ56.SGD","LU1244550494.USD","LU1496350502.SGD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0122379950.USD","LU1732799900.SGD","LU0683600562.USD","LU1914381329.SGD","LU0345770993.USD","LU0787776722.HKD","LU1585245621.USD","LU1674673691.USD","LU1778281490.HKD","LU2471134879.HKD","LU1066053197.SGD","BK4504","IE0034235303.USD","LU0098860793.USD","LU2750360641.GBP","IE00BLSP4452.SGD","IE00BZ1G4Q59.USD","BK4532","LU0234572021.USD","LU0889566641.SGD","LU0320765646.SGD","IE00BDGV0183.EUR","LU1162221912.USD","IE00BSNM7G36.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU0912757837.SGD","IE00BN8TJ469.HKD","LU0203347892.USD","BK4559","LU0795875086.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4588","LU2471134952.CNY","LU1221951129.SGD","LU2129689514.USD","LU2468319806.SGD","JNJ","LU0345769128.USD","IE00BLSP4239.USD","LU2750360997.AUD","LU1894683348.USD","LU2602419157.SGD","LU1244550221.USD","LU1983299246.USD","LU1280957306.USD","IE00B3PB1722.GBP","LU1674673428.USD","LU0124676726.USD","BK4007","LU2347655156.SGD","BK4550","IE00B19Z3581.USD","LU1066051498.USD","LU0114720955.EUR","LU1929549753.HKD","SG9999002232.USD","LU2505996681.GBP","IE00BVYPNW00.USD","IE00B42XCP33.USD"],"gpt_icon":0},{"id":"1160878033","title":"Rybrevant Faspro™联合免疫疗法一线治疗复发或转移性头颈癌展现强劲临床获益，总缓解率达56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160878033","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160878033?lang=zh_cn&edition=full","pubTime":"2026-02-20 06:03","pubTimestamp":1771538631,"startTime":"0","endTime":"0","summary":"最新临床研究数据显示，Rybrevant Faspro™（Amivantamab与透明质酸酶-Lpuj复方制剂）与免疫疗法联合方案，在用于一线治疗复发或转移性头颈癌时，展现出显著的临床效益。该治疗方案实现了56%的总缓解率，凸显了其在难治性癌症领域的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BBT3K403.USD","LU0234572021.USD","IE00B3PB1722.GBP","LU0432979614.USD","LU0795875169.SGD","LU1983299246.USD","LU0345769631.USD","BK4592","IE00BN8TJ469.HKD","LU1023059063.AUD","LU1496350502.SGD","LU0114720955.EUR","LU2129689431.USD","LU1894683264.USD","BK4559","LU2505996681.GBP","IE00BFXG1179.USD","IE00B19Z3581.USD","LU0124676726.USD","BK4550","LU2089984988.USD","BK4585","LU0345770993.USD","LU0070217475.USD","LU2129689605.HKD","IE00B4R5TH58.HKD","BK4534","LU1074936037.SGD","LU0683600562.USD","IE0002270589.USD","IE0002141913.USD","LU1244550494.USD","BK4533","LU1162221912.USD","JNJ","LU1280957306.USD","LU1066051498.USD","LU2471134796.USD","IE00BVYPNW00.USD","LU2112291526.USD","LU0345769128.USD","IE00BZ1G4Q59.USD","LU2750360997.AUD","SG9999002224.SGD","LU0689626769.HKD","LU0320765646.SGD","IE00B1BXHZ80.USD","LU1057294990.SGD","LU2505996509.AUD","LU2129689514.USD","SG9999002232.USD","IE000M9KFDE8.USD","BK4568","LU0912757837.SGD","BK4532","LU2750360641.GBP","LU1066051225.USD","LU1430594728.SGD","LU1732800096.USD","LU1894683348.USD","LU2347655156.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B3T34201.USD","BK4581","LU1585245621.USD","IE00B42XCP33.USD","LU2471134879.HKD","LU0787776722.HKD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU0122379950.USD","LU0882574055.USD","LU1059921491.USD","LU0098860793.USD","LU1929549753.HKD","LU2592432038.USD","LU2430703095.HKD","LU1066051811.HKD","LU0795875086.SGD","LU0203347892.USD","LU2471134523.USD","LU1244550577.SGD","LU2468319806.SGD","LU0640476718.USD","LU1221951129.SGD","SG9999001440.SGD","LU0345770308.USD","LU0792757196.USD","LU1914381329.SGD","LU1267930813.SGD","IE00BKVL7J92.USD","LU1935042991.SGD","LU2430703251.USD","LU1221951046.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0889566641.SGD","IE00B7SZLL34.SGD","IE0034235303.USD","LU1032466523.USD","LU2430703178.SGD","LU1732799900.SGD","LU0234570918.USD","BK4588","IE00BFTCPJ56.SGD","LU1674673428.USD","LU2471134952.CNY","IE00BSNM7G36.USD","LU1196500208.SGD","LU0058720904.USD","IE00BDGV0183.EUR","LU1718418525.SGD","LU2133065610.SGD","LU1032955483.USD","LU2602419157.SGD","LU1261432733.SGD","LU1674673691.USD","BK4504","LU1066053197.SGD","LU1506573853.SGD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","LU1778281490.HKD","LU1244550221.USD","LU1061106388.HKD","LU0466842654.USD","LU0985320562.USD","LU0203345920.USD","IE00BGHQF631.EUR","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2612928724","title":"强生探索出售骨科业务 估值或超200亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612928724","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612928724?lang=zh_cn&edition=full","pubTime":"2026-02-20 03:43","pubTimestamp":1771530180,"startTime":"0","endTime":"0","summary":"据知情人士透露，强生酝酿出售其计划分拆的骨科业务部门，大型私募股权机构已开始关注潜在交易。\n DePuy Synthes业务在出售时的估值可能超过200亿美元。强生已在整理DePuy Synthes的相关文件和财务资料，以便在未来几周与潜在买家会面。据悉，多家大型私募股权公司正考虑联合收购该业务。\n DePuy Synthes生产用于髋关节和膝关节置换的器械，去年实现销售额93亿美元。该业务也可能吸引竞争对手医疗器械公司的兴趣。\n 目前讨论仍处于早期阶段，尚不能保证最终会达成出售。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：李桐","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-20/doc-inhnkyhw6563375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2430703178.SGD","LU0345769631.USD","LU1162221912.USD","BK4568","LU2505996681.GBP","BK4534","LU1059921491.USD","LU1929549753.HKD","IE00B19Z3581.USD","BK4581","LU0234570918.USD","LU0795875169.SGD","LU1894683264.USD","IE00BBT3K403.USD","BK4532","LU0787776722.HKD","LU0124676726.USD","LU1983299246.USD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU1032955483.USD","IE00BKVL7J92.USD","LU1674673691.USD","LU2112291526.USD","LU1496350502.SGD","LU2471134879.HKD","LU1267930813.SGD","SG9999002232.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU0689626769.HKD","IE00B1BXHZ80.USD","BK4588","LU0070217475.USD","LU1066051811.HKD","LU1074936037.SGD","LU0345769128.USD","IE00BJJMRZ35.SGD","LU0985320562.USD","IE00BLSP4239.USD","IE00B3T34201.USD","JNJ","LU1032466523.USD","BK4585","LU1280957306.USD","IE00BFTCPJ56.SGD","BK4533","LU1732799900.SGD","LU2129689514.USD","LU0889566641.SGD"],"gpt_icon":0},{"id":"1145539231","title":"强生股价短暂冲高 消息称公司正评估骨科业务部门","url":"https://stock-news.laohu8.com/highlight/detail?id=1145539231","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145539231?lang=zh_cn&edition=full","pubTime":"2026-02-20 03:26","pubTimestamp":1771529174,"startTime":"0","endTime":"0","summary":"据知情人士透露，医疗保健巨头强生正在对其骨科业务部门进行战略评估，此举可能涉及该部门的未来发展方向调整。受此消息影响，强生股价在盘中出现短暂拉升，最终收盘涨幅定格在0.5%。\n市场分析师指出，骨科业务作为强生医疗设备板块的重要组成部分，其战略调整将直接影响公司整体业务布局。此次评估可能包括业务重组、合作伙伴关系调整或潜在的战略选择方案。\n投资者密切关注此次评估可能带来的结构性变化，认为这或将成为强生优化产品组合、提升市场竞争力的关键举措。股价的即时反应也体现了市场对潜在业务调整的积极预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051811.HKD","LU0124676726.USD","LU0289739699.SGD","LU1983299246.USD","LU2129689605.HKD","LU2592432038.USD","LU1732799900.SGD","LU0795875169.SGD","LU1074936037.SGD","SG9999001440.SGD","IE00B42XCP33.USD","IE00B4R5TH58.HKD","IE00BLSP4239.USD","LU2471134952.CNY","LU2750360997.AUD","LU2430703251.USD","LU2129689514.USD","BK4533","IE00BLSP4452.SGD","LU1057294990.SGD","LU1496350502.SGD","LU1032466523.USD","LU2471134796.USD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","IE0009355771.USD","LU0098860793.USD","LU0114720955.EUR","IE00BFXG1179.USD","LU1430594728.SGD","IE00BVYPNV92.GBP","LU2129689431.USD","LU1162221912.USD","LU2750360641.GBP","LU2602419157.SGD","LU1066053197.SGD","LU2471134523.USD","LU0683600562.USD","BK4559","LU0882574055.USD","LU1718418525.SGD","LU0320765646.SGD","LU2505996509.AUD","IE00B3PB1722.GBP","IE00B3T34201.USD","LU1506573853.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU1244550221.USD","IE0034235303.USD","IE00BSNM7G36.USD","IE00B1BXHZ80.USD","LU1585245621.USD","LU1778281490.HKD","LU2347655156.SGD","LU1244550494.USD","LU2430703095.HKD","LU0912757837.SGD","IE00B19Z3B42.SGD","BK4592","LU1059921491.USD","BK4532","BK4585","LU0889566641.SGD","IE0002270589.USD","LU2430703178.SGD","LU2112291526.USD","LU1061106388.HKD","BK4504","SG9999002232.USD","LU0640476718.USD","LU1066051225.USD","LU0787776722.HKD","BK4534","IE00BBT3K403.USD","LU0795875086.SGD","LU0234570918.USD","LU0345770308.USD","BK4588","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU1267930813.SGD","IE0002141913.USD","IE00BN8TJ469.HKD","LU0432979614.USD","IE000M9KFDE8.USD","LU0203347892.USD","LU0985320562.USD","LU1221951046.USD","LU1894683264.USD","LU1929549753.HKD","IE00BVYPNW00.USD","LU2505996681.GBP","BK4550","LU1674673428.USD","LU0070217475.USD","LU1732800096.USD","LU1023059063.AUD","LU0203345920.USD","LU2468319806.SGD","LU1914381329.SGD","BK4581","IE00BKVL7J92.USD","LU1935042991.SGD","LU0122379950.USD","LU1066051498.USD","LU0345769128.USD","LU1894683348.USD","LU0345769631.USD","LU1674673691.USD","LU1261432733.SGD","LU0058720904.USD","LU0689626769.HKD","SG9999002224.SGD","LU0792757196.USD","BK4007","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU2471134879.HKD","LU0345770993.USD","LU1221951129.SGD","LU1280957306.USD","LU1196500208.SGD","LU1244550577.SGD","LU1032955483.USD","LU2133065610.SGD","BK4568","IE00BDGV0183.EUR","LU0234572021.USD","IE00B19Z3581.USD","JNJ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com;www.investor.jnj.com;www.factsabouttalc.com","stockEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":0.0108},{"period":"3month","weight":0.2132},{"period":"6month","weight":0.38},{"period":"1year","weight":0.4553},{"period":"ytd","weight":0.1722}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.00367},{"month":2,"riseRate":0.521739,"avgChangeRate":-0.001555},{"month":3,"riseRate":0.586957,"avgChangeRate":0.015766},{"month":4,"riseRate":0.630435,"avgChangeRate":0.032381},{"month":5,"riseRate":0.478261,"avgChangeRate":-0.025904},{"month":6,"riseRate":0.5,"avgChangeRate":0.005615},{"month":7,"riseRate":0.608696,"avgChangeRate":0.013965},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005146},{"month":9,"riseRate":0.5,"avgChangeRate":0.003517},{"month":10,"riseRate":0.695652,"avgChangeRate":0.021187},{"month":11,"riseRate":0.608696,"avgChangeRate":0.017686},{"month":12,"riseRate":0.652174,"avgChangeRate":0.01226}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}